Bill Gates Talks to TIME About a Coming ‘Third Wave’ of Development in Africa
There’s a very big difference between simple and easy—especially when it comes to global health. It’s simple to eradicate polio—just get all children are vaccinated. It’s simple to reduce nighttime malaria infections—make sure everyone in malaria-endemic areas sleeps under a bed net. But none of that is easy. The tension between simple and easy is at play when it comes to eradicating poverty in the developing world too, as the Bill & Melinda Gates Foundation makes clear in its second annual Goalkeepers Data Report. In a conversation with TIME, Bill Gates points to two recent waves of...
Source: TIME: Health - September 21, 2018 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized onetime public health Source Type: news

Medical News Today: Fighting brain cancer with the Zika virus
Scientists have found some surprising common ground between the Zika virus and brain cancer. They hope that a Zika vaccine may help combat glioblastoma. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 21, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

DNA vaccine leads to immune responses in HPV-related head and neck cancer
(University of Pennsylvania School of Medicine) A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus (HPV)-related head and neck cancer. Researchers from the Abramson Cancer Center of the University of Pennsylvania tested the immunotherapy approach in two groups of patients with advanced head and neck squamous cell carcinoma (HNSCCa) and found 86 percent showed elevated T cell activity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 21, 2018 Category: Cancer & Oncology Source Type: news

Analysis finds HPV vaccine safe
(Wiley) Infection with human papillomavirus (HPV) can cause certain cancers in women and men, but HPV vaccines are highly effective in preventing infection with oncogenic HPV types. A new British Journal of Clinical Pharmacology review of post-licensure data did not identify any new or unexpected safety concerns of the bivalent HPV vaccine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 19, 2018 Category: International Medicine & Public Health Source Type: news

Zika vaccine shows promise against brain cancer
A Zika virus successfully killed off human glioblastoma brain cancer stem cells transplanted into mice, according to a study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 18, 2018 Category: Consumer Health News Source Type: news

UTMB adapts Zika vaccine to fight brain cancer
(University of Texas Medical Branch at Galveston) Researchers at The University of Texas Medical Branch at Galveston have successfully harnessed their Zika virus vaccine to target and kill brain cancer known as glioblastoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 18, 2018 Category: Cancer & Oncology Source Type: news

Zika vaccine shows promise for treating deadly brain cancer
(American Society for Microbiology) An international team of researchers has successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells, which had been transplanted into mice. In a study published this week in mBio ® , the team shows that a live, attenuated version of the Zika virus could form the basis of a new treatment option for this fatal brain cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 18, 2018 Category: Biology Source Type: news

Cancer Will Kill About 10 Million People This Year, Experts Predict
Nearly 10 million people around the world will die of cancer this year, according to new estimates from the World Health Organization’s International Agency for Research on Cancer (IARC). The IARC’s report, which was published Wednesday in CA: A Cancer Journal for Clinicians, was based on cancer incidence data from 185 countries around the world. Researchers estimated that there will be 18.1 million new diagnoses of cancer and 9.6 million cancer deaths in 2018. Those numbers — a marked increase from just six years ago, when cancer diagnoses were estimated at 14.1 million, and deaths at 8.2 million —...
Source: TIME: Health - September 14, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer healthytime Innovation Health Source Type: news

Rush clinical trial testing vaccine for glioblastoma brain cancer
(Rush University Medical Center) Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients' immune systems stop the spread of glioblastoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 13, 2018 Category: Cancer & Oncology Source Type: news

Medics who turn down the winter flu jab could be kept away from cancer patients and sick babies
Professor Jane Cummings, England's chief nurse, said 'myths' persist around the vaccine, including among doctors and nurses, with the 'big one' being it gives people flu. (Source: the Mail online | Health)
Source: the Mail online | Health - September 12, 2018 Category: Consumer Health News Source Type: news

Africa:Stopping Cervical Cancer and Other Noncommunicable Diseases in Africa
[WHO] As she felt the cold sting of the needle enter her arm, Alice winced in fear more than pain- understandable as she is only 10. However, a moment of pain could save her from the leading cause of cancer death among women in Africa: cervical cancer. She is receiving a vaccine against human papilloma virus (HPV), the main gateway agent in cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 12, 2018 Category: African Health Source Type: news

Cancer vaccine hope as scientists cure skin melanoma in 100% of mice
Researchers at the Scripps Research Institute and the University of Texas injected mice with an immunotherapy drug and a chemical called Diprovocim, which made the jab more effective. (Source: the Mail online | Health)
Source: the Mail online | Health - September 12, 2018 Category: Consumer Health News Source Type: news

Hope for a cancer vaccine as scientists cure skin melanoma in 100% of mice in a trial
Researchers at the Scripps Research Institute and the University of Texas injected mice with an immunotherapy drug and a chemical called Diprovocim, which made the jab more effective. (Source: the Mail online | Health)
Source: the Mail online | Health - September 12, 2018 Category: Consumer Health News Source Type: news

Controversial chiropractor still posting videos while under investigation
A Halifax-based chiropractor being investigated for online posts that include discredited views on vaccines and cancer therapies continues to share controversial information on social media that is outside her scope of practice. (Source: CBC | Health)
Source: CBC | Health - September 11, 2018 Category: Consumer Health News Tags: News/Canada/Nova Scotia Source Type: news

Medical News Today: New cancer vaccine is 100 percent successful in mouse model
A team of experts has conducted tests in mice for a potent new vaccine against melanoma. So far, the researchers have observed a 100 percent success rate. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 10, 2018 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news

New discovery on T cell behavior has major implications for cancer immunotherapy
(University of Colorado Anschutz Medical Campus) Scientists at the University of Colorado Anschutz Medical Campus have discovered that disease-fighting T cells, elicited from vaccines, do not require glucose for their rapid reproduction, a finding with major implications for the development of immunotherapies for cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 7, 2018 Category: Cancer & Oncology Source Type: news

Scientists test new cancer vaccine against melanoma
(Scripps Research Institute) The findings suggest these vaccines could increase chances of recovery in cases where a drug therapy alone is not working. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 6, 2018 Category: International Medicine & Public Health Source Type: news

Uganda:Uganda Could Lose Cervical Cancer Vaccine Funding
[East African] Uganda risks losing funding for cervical cancer vaccination, after the country failed to meet the targets required to qualify for national support from the Global Alliance for Vaccines and Immunisation (GAVI). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 5, 2018 Category: African Health Source Type: news

Clinical trial testing topical cream plus influenza vaccine in progress
(NIH/National Institute of Allergy and Infectious Diseases) A Phase 1 clinical trial examining whether a topical cream can enhance the immune response conferred by a 'pre-pandemic' influenza vaccine is underway at Baylor College of Medicine, a Vaccine and Treatment Evaluation Unit (VTEU) funded by NIAID. Investigators are evaluating whether imiquimod cream, commonly used to treat genital warts and certain skin cancers, can boost the body's immune response to an H5N1 influenza vaccine. The trial is enrolling 50 healthy adults ages 18-50 years. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 5, 2018 Category: Infectious Diseases Source Type: news

Editors of medical journals confirm: HPV vaccines cause more harm than good... science author facing death threats
(Natural News) In medicine, sometimes preventive measures and treatments have the opposite effect. Whether it’s antidepressants making people suicidal or chemotherapy spreading cancer rather than decimating it, it’s shocking just how bad some of these supposed solutions to health problems really are. Now, a new contender has emerged in the form of the HPV vaccine.... (Source: NaturalNews.com)
Source: NaturalNews.com - August 30, 2018 Category: Consumer Health News Source Type: news

Requiring insurers to cover retail pharmacy vaccinations for adult Californians could save lives, study finds
Requiring health insurers to pay for adult vaccinations given at retail pharmacies could help prevent the spread of deadly communicable diseases such as influenza, pneumococcal infection and human papillomavirus, according to a  new study by the UCLA Center for Health Policy Research.Many insurers do not cover pharmacy-administered vaccines; cover a limited selection of vaccines; or require people they insure to get vaccinated only at pharmacies within their insurance network, the study reports.Overall vaccination rates in state are lowThe overall vaccination rate among adult Californians is far below federa...
Source: UCLA Newsroom: Health Sciences - August 30, 2018 Category: Universities & Medical Training Source Type: news

Vaccine tied to drop in HPV cases still not reaching half of U.S. kids
(Reuters Health) - Although a vaccine for the cancer-causing human papillomavirus (HPV) has led to a dramatic decrease in infections, a new study suggests that half of U.S. teens are still not fully vaccinated against this virus. (Source: Reuters: Health)
Source: Reuters: Health - August 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

HPV-related cancer rises, despite higher vaccination rates
The number of cancer cases associated with the human papillomavirus (HPV) is growing even as an increasing number of adolescents are being vaccinated against HPV. According to the Centers for Disease Control and Prevention, more than 43,000 people developed HPV-associated cancer in 2015, compared with about 30,000 in 1999, STAT reports, with throat cancer now the most common HPV-related malignancy. But the CDC also reported that the percentage of adolescen ts receiving all the recommended doses… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 24, 2018 Category: American Health Authors: Anne Stych Source Type: news

HPV Vaccination Rates Rising Among U.S. Teens
Nearly 66 percent of boys and girls aged 13 to 17 received the first dose in the HPV vaccine series in 2017, according to the U.S. Centers for Disease Control and Prevention researchers. And nearly 49 percent of adolescents received all the recommended doses to complete the series. The human papillomavirus (HPV) causes most cases of cervical cancer. (Source: WebMD Health)
Source: WebMD Health - August 23, 2018 Category: Consumer Health News Source Type: news

More Teenagers Than Ever Are Getting the HPV Vaccine, CDC Says
More teenagers than ever before are getting vaccinated against human papillomavirus (HPV), according to new data from the Centers for Disease Control and Prevention (CDC). Federal guidelines now say that all children should start two-dose HPV vaccination at age 11 or 12 to protect against HPV-associated cervical, vaginal, penile, anal and throat cancers. Despite that recommendation, however, HPV vaccination rates have traditionally lagged far below their targets. That’s still true — but the new report does suggest that rates are rising. Between 2016 and 2017, the CDC says, the percentage of teenagers who report...
Source: TIME: Health - August 23, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime public health Source Type: news

Rise in HPV-related cancers DESPITE rise in vaccine coverage
In 2015, 43,000 Americans were diagnosed with a cancer related to the human papillomavirus - up from 30,000 in 1999. We may still be a few years off seeing the effects of the vaccine. (Source: the Mail online | Health)
Source: the Mail online | Health - August 23, 2018 Category: Consumer Health News Source Type: news

HPV Vaccination Rates Rising Among U.S. Teens
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - August 23, 2018 Category: Cancer & Oncology Source Type: news

Steam treatment for enlarged prostate approved for use on NHS
Transurethral water vapour ablation may cause less sexual dysfunction than current surgical options as it is less invasive Related items fromOnMedica JCVI recommends universal HPV vaccination Genetic risk model could guide prostate cancer screening Some doctors misunderstand smear test says GP UK facing sperm donor crisis Men with highly active jobs tend to die earlier than men with inactive jobs (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 22, 2018 Category: UK Health Source Type: news

HPV Testing Can Replace Pap Smears for Many Women, New Guidelines Say
Pap smears, long the gold standard for cervical cancer screening, may be used less frequently under new guidelines from the U.S. Preventive Services Task Force. The recommendations, which were published Tuesday in JAMA, say that women between ages 30 and 65 can rely on human papillomavirus (HPV) testing instead of, or in addition to, Pap smears. Women in this age group should get HPV testing every five years, a Pap smear every three years or a combination of the two tests every five years, the guidelines say. HPV causes the vast majority of cervical cancer cases, according to the National Cancer Institute, which makes HPV ...
Source: TIME: Health - August 21, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer healthytime Innovation Health onetime Source Type: news

Ichor touts use of electroporation drug-delivery system in cervical cancer trial
Ichor Medical Systems said today that its TriGrid electroporation drug-delivery system was tapped for a Phase Ib/II clinical trial to administer an investigational therapeutic HPV DNA vaccine, GX-188E, developed by Genexine Inc. The trial is designed to test the efficacy of a DNA vaccine combined with an anti-PD-1 therapy in patients with HPV-induced advanced non-resectable cervical cancer. Get the full story at our sister site, Drug Delivery Business News. The post Ichor touts use of electroporation drug-delivery system in cervical cancer trial appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 21, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Pharmaceuticals Wall Street Beat Ichor Medical Systems Source Type: news

One in 50 carry HPV in their throats
Smokers and people who have had more sexual and oral sexual partners are most at risk Related items fromOnMedica JCVI recommends universal HPV vaccination The HPV vaccine, ten years on Boys will receive HPV vaccine Nurse guidance published on cervical cancer and HPV Experts welcome new evidence on HPV jab efficacy and safety (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 21, 2018 Category: UK Health Source Type: news

The HPV Vaccine: Access and Use in the U.S.
This factsheet discusses HPV and related cancers, use of the HPV vaccines for both females and males, and insurance coverage and access to the vaccines. (Source: PHPartners.org)
Source: PHPartners.org - August 14, 2018 Category: International Medicine & Public Health Source Type: news

Researchers artificially generate immune cells integral to creating cancer vaccines
For the first time, Mount Sinai researchers have identified a way to make large numbers of immune cells that can help prevent cancer reoccurrence, according to a study published in August in Cell Reports. The researchers discovered a way to grow the immune cells, called dendritic cells, at large scale in the lab to study them for their potential use in highly refined cancer vaccines to prevent patients' cancer from coming back. (Source: World Pharma News)
Source: World Pharma News - August 14, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Researchers artificially generate immune cells integral to creating cancer vaccines
(The Mount Sinai Hospital / Mount Sinai School of Medicine) For the first time, Mount Sinai researchers have identified a way to make large numbers of immune cells that can help prevent cancer reoccurrence, according to a study published in August in Cell Reports. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 14, 2018 Category: Cancer & Oncology Source Type: news

State HPV vaccine laws do not appear to influence teen sex
(Reuters Health) - State laws designed to increase teen vaccination against the cancer-causing human papillomavirus (HPV) don't appear to influence adolescents' choices about whether to become sexually active or use condoms, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - August 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Promoting HPV Vaccine Doesn't Prompt Risky Sex by Teens: Study
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - August 13, 2018 Category: Cancer & Oncology Source Type: news

Moderna's head of oncology leaves to helm new Cambridge cancer biotech Oncorus
The head of oncology at Moderna Therapeutics leaving the $7 billion biotech company to lead small Cambridge cancer startup Oncorus Inc., the startup announced Wednesday. Ted Ashburn's exit comes as the Moderna is finishing construction on its new personalized cancer vaccine unit in Norwood and preparing to move nearly two dozen highly anticipated messenger RNA programs through clinical trials. Moderna has 11 preclinical programs with another 10 in clinical trails, including one that has entered… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 1, 2018 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

HPV vaccine to be given to boys in England
The government has announced that adolescent boys aged 12 and 13 will be offered the human papilloma virus (HPV) vaccine to protect them from cancer. (Source: NHS Networks)
Source: NHS Networks - July 25, 2018 Category: UK Health Source Type: news

Boys will receive HPV vaccine
The vaccine, which is already given to girls, will be given to boys aged 12 to 13 in England Related items fromOnMedica Vaccine could 'eradicate' cervical cancer The HPV vaccine, ten years on JCVI recommends universal HPV vaccination Experts welcome new evidence on HPV jab efficacy and safety HPV vaccination to be offered to men who have sex with men (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 25, 2018 Category: UK Health Source Type: news

Teenage boys to be vaccinated against cancer-causing HPV
Inoculation programme will be expanded to cover 12- and 13-year-old boys in EnglandBoys aged 12 and 13 in England are to be vaccinated against the cancer-causing human papilloma virus (HPV), the government has said.The decision, announced on Tuesday, comes after theJoint Committee on Vaccination and Immunisation (JCVI) recommended last week that the HPV vaccination, which protects girls against cervical cancer, should be extended to boys. It followed growing calls for theinoculation programme to be expanded.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 24, 2018 Category: Science Authors: Haroon Siddique Tags: HPV vaccine Cancer Cervical cancer Science UK news Health Society Vaccines and immunisation Source Type: news

HPV vaccine UK: Jab that protects against cervical cancer will now also be given to boys
HPV VACCINE in the UK protects against cervical cancer. Up until now all girls can get the jab free from the NHS from the age of 12 up to their 18th birthday. But now boys will also be given the vaccine, the Government has announced. (Source: Daily Express - Health)
Source: Daily Express - Health - July 24, 2018 Category: Consumer Health News Source Type: news

Teenage boys in England will be vaccinated against HPV
The NHS will embark on a £20 million a year programme to vaccinate all 12 and 13 year old males against the sexually transmitted human papillomavirus, which causes oral cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - July 24, 2018 Category: Consumer Health News Source Type: news

HPV Vaccine Eliminates Advanced Skin Cancer in 97-Year-Old
TUESDAY, July 24, 2018 -- The 9-valent human papillomavirus (HPV) vaccine could be a therapeutic option for patients with cutaneous squamous cell carcinoma when surgical management is not an option, according to a case report published online July 3... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news

Government announces HPV vaccine to be given to boys in England
The government has announced today that adolescent boys in England will be offered the human papilloma virus (HPV) vaccine to protect them from cancer. (Source: Nursing Times)
Source: Nursing Times - July 24, 2018 Category: Nursing Source Type: news

Six Ways Artificial Intelligence Is Impacting Patients
It ’s difficult to open a newspaper nowadays without seeing an article about artificial intelligence. These column-inches spark our imaginations with heady visions of possible futures and crease our brows with concern in equal measure. But one thing you cannot escape is that AI is here now and it’s only going to become more pervasive.While fear of an unknown technology is understandable, in many ways it does a disservice to the incredible impact that AI is already having on the world around us. In the healthcare space alone, it is offering ways to fundamentally rethink clinical practice, speeding up diagnosis, ...
Source: EyeForPharma - July 24, 2018 Category: Pharmaceuticals Authors: Lucy Fulford Source Type: news

Boosting HPV Vaccinations in Rural Florida (Free CE, September 6th 2018, Starke FL)
September 6th, 2018, Starke, FL, free CE. Attendees will leave this summit better able to recommend the vaccine to patients and parents in their practice. They will learn the impact that HPV-associated cancers can have on patients, how to report their vaccination rates to Florida's database, best practices for dealing with vaccine hesitancy, and more. (Source: PHPartners.org)
Source: PHPartners.org - July 24, 2018 Category: International Medicine & Public Health Source Type: news

Lies.news reveals the truth on all the latest fake news, fake science and other propaganda
(Natural News) Fake news and propaganda is everywhere: Whether you’re talking about vaccines, food, pesticides or politics, the truth is often buried beneath a layer of industry-funded filth. The entire Monsanto corporation and the recent drama surrounding their cancer-causing herbicide is proof of that: The company actually set out to orchestrate public outcry to discredit... (Source: NaturalNews.com)
Source: NaturalNews.com - July 20, 2018 Category: Consumer Health News Source Type: news

Government advisors back extending HPV vaccine to boys
School age boys in the UK should be offered vaccination against the cancer causing human papillomavirus (HPV), according to government advisors. (Source: Nursing Times)
Source: Nursing Times - July 19, 2018 Category: Nursing Source Type: news

JCVI recommends universal HPV vaccination
Doctors and sexual health experts welcome statement that boys should get HPV jab Related items fromOnMedica The HPV vaccine, ten years on Nurse guidance published on cervical cancer and HPV Experts welcome new evidence on HPV jab efficacy and safety HPV vaccination to be offered to men who have sex with men HPV vaccination in boys deemed not cost effective (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 19, 2018 Category: UK Health Source Type: news

Boys set to receive HPV jab after JCVI recommendation
The Joint Committee on Vaccination and Immunisations (JCVI) has recommended that the HPV immunisation programme should be extended to cover boys. (Source: GP Online News)
Source: GP Online News - July 18, 2018 Category: Primary Care Tags: Cancer Source Type: news